NCT05434572

Brief Summary

The purpose of this research repository is to collect, store, and share with other researchers any tissues that subjects with all types of neuromuscular disease are willing to donate. These samples will be stored at Virginia Commonwealth University (VCU) and will be used for future research with this population.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
45mo left

Started Mar 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Mar 2021Feb 2030

Study Start

First participant enrolled

March 17, 2021

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

June 21, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 28, 2022

Completed
7.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2030

Last Updated

July 4, 2025

Status Verified

July 1, 2025

Enrollment Period

8.8 years

First QC Date

June 21, 2022

Last Update Submit

July 1, 2025

Conditions

Keywords

NeuromuscularResearch RepositoryBiobankNeuromuscular Disorder

Outcome Measures

Primary Outcomes (1)

  • To collect, store, and share with other researchers any tissues that subjects with all types of neuromuscular disease are willing to donate.

    Subjects will have the opportunity to provide the following samples: saliva or cheek swab, urine sample (up to 15ml), feces (up to 2mg of a stool sample), blood (up to 40ml), muscle biopsy tissue, and cell line (subjects have the option to allow a cell line to be made from their blood, muscle, or skin biopsies to provide a renewable supply of DNA and other cell components for research)

    Baseline

Secondary Outcomes (1)

  • To collect medical history information from subjects with all types of neuromuscular disease and healthy controls.

    Baseline

Eligibility Criteria

AgeUp to 75 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This is a very inclusive study that will allow samples from known subjects of sites' neuromuscular clinics, associated family members, and healthy volunteers. This study will include subjects with any form of neuromuscular disorder, including neuromuscular disorders of unknown etiology.

You may qualify if:

  • Willing and able to give informed consent
  • Positive diagnosis or suspected diagnosis of neuromuscular disease, or
  • Family history of neuromuscular disease, or
  • Healthy volunteer
  • Age Neonates-75

You may not qualify if:

  • Unwilling to sign consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

As part of this repository, subjects will also have the option to allow a cell line to be made from their blood, muscle, or skin biopsies to provide a renewable supply of DNA and other cell components for research. A cell line is a frozen sample of specially processed cells from blood that allows us to grow more cells and obtain more DNA and other cell components, such as RNA or proteins, for future research. The cell line would not be labeled with the subjects name, address, birthdate, or other personal identifiers.

MeSH Terms

Conditions

Neuromuscular Diseases

Condition Hierarchy (Ancestors)

Nervous System Diseases

Study Officials

  • Nicholas E. Johnson, MD

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2022

First Posted

June 28, 2022

Study Start

March 17, 2021

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

February 1, 2030

Last Updated

July 4, 2025

Record last verified: 2025-07

Locations